INHBA/Activin A promotes tumor growth and induces resistance to anti-PD-L1 therapy by suppressing IFN-γ signaling
F. Li, L. Gu, Y. Tong, X. Yu, R. Chen, N. Liu, S. Chen, J. Lu, Y. Si, J. Chen, J. Sun, Y. Long, L. Gong
This study shows that INHBA/activin A suppresses IFN-γ signaling, leading to resistance to anti-PD-L1 therapy and promoting tumor growth.
bioRxiv · Dec 7, 2023 · PreprintImmunology